Facebook Linkedin RSS Twitter Youtube
Home 2024

HIV drug discovery

HIV Vaccine Triggered Elusive Broadly Neutralizing HIV Antibodies, Trial Shows
Infectious Diseases

HIV Vaccine Triggered Elusive Broadly Neutralizing HIV Antibodies, Trial Shows

Caring Cross and Fiocruz Partner for Low-Cost CAR-T Manufacturing in Brazil
Bioprocessing

Caring Cross and Fiocruz Partner for Low-Cost CAR-T Manufacturing in Brazil

Novel Insights into RNA Modification in HIV-1 Revealed
Infectious Diseases

Novel Insights into RNA Modification in HIV-1 Revealed

Dormant HIV May Actively Impact Immune Response
Infectious Diseases

Dormant HIV May Actively Impact Immune Response

AGT Spins Out Addimmune, Focusing on Functional HIV Cure
Drug Discovery

AGT Spins Out Addimmune, Focusing on Functional HIV Cure

Latent HIV Reservoir in CSF May Pose Treatment Challenges
Infectious Diseases

Latent HIV Reservoir in CSF May Pose Treatment Challenges

HIV Drug Candidate Opens “Shock and Kill” Possibilities
Drug Discovery

HIV Drug Candidate Opens “Shock and Kill” Possibilities

Low Patient Enrollment Threatens Cancer Trials
Insights

Low Patient Enrollment Threatens Cancer Trials

FDA Approves Viiv Healthcare’s HIV-1 Treatment Tivicay
Infectious Diseases

FDA Approves Viiv Healthcare’s HIV-1 Treatment Tivicay

HIV Drug Consortium Wins Over $5M in EU Funding
Industry News

HIV Drug Consortium Wins Over $5M in EU Funding

123Page 1 of 3
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.